Title:
カリウムチャネル阻害剤として有用なベンゾイミダゾール誘導体
Document Type and Number:
Japanese Patent JP7097435
Kind Code:
B2
Abstract:
A compound of the general formula (I). The compounds of formula I are useful for treatment of a cardiac disease, disorder or condition in a mammal.
Inventors:
Sorensen, Ulrik
Mete, Antonio
Mete, Antonio
Application Number:
JP2020511190A
Publication Date:
July 07, 2022
Filing Date:
August 22, 2018
Export Citation:
Assignee:
Ascion Pharma ASP
International Classes:
C07D235/30; A61K31/4184; A61K31/422; A61K31/4245; A61K31/4439; A61K31/506; A61P9/00; A61P9/06; C07D401/12; C07D403/12; C07D405/12; C07D413/12
Domestic Patent References:
| JP2020530479A | ||||
| JP2019506442A | ||||
| JP2008526815A | ||||
| JP2008509111A |
Foreign References:
| WO2013104577A1 |
Other References:
ULRIK S. SOERENSEN ET AL.,Synthesis and Structure-Activity Relationship Studies of 2-(N-Substituted)-aminobenzimidazoles as Potent Negative Gating Modulators of Small Conductance Ca 2+ -Activated K + Channels,JOURNAL OF MEDICINAL CHEMISTRY,2008年,vol.51, no.23,p.7625-7634
Attorney, Agent or Firm:
Asamura patent office